The genetic labs and genomics experts we choose to work with are an extension of our company, therefore we ensure that we choose exemplary partners. RUCDR Infinite Biologics handles our DNA extraction and genotyping, Illumina provides the technology that handles our genome genotyping, and MyGenomics (our genomics experts in Europe) analyzes the genotypes and creates personalized genomics reports for our clients. These partners ensure the highest quality for our clients in terms of accuracy and privacy.
RUCDR Infinite Biologics®
RUCDR Infinite Biologics is the world’s largest university-based biorepository and has been perfecting the fields of biobanking, bioprocessing, and analytics since 1999. They use technologically advanced infrastructures, state-of-the-art scientific approaches, and the highest quality biomaterials to fulfill their mission of understanding the genetic causes of common, complex diseases and the ways to diagnose, treat and cure those diseases.
RUCDR Infinite Biologics is accredited by the College of American Pathologists, a worldwide leader in laboratory quality assurance, and adheres to “ISBER Best Practices” guidelines, which are considered the gold standard in Biobanking practices.
The highest level of privacy and anonymity is ensured through RUCDR’s barcode de-identification process. No personally identifiable information is ever included on tubes, and all samples are tracked through barcodes.
Illumina is a global leader in the field of genomics and is a leading developer and manufacturer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Their leading-edge sequencing and array-based solutions assist the advancement of disease research, drug development, and the development of molecular tests.
My Genomics™ is a European-based genomics company that uses cutting-edge technology and a team of scientific advisors to produce accurate and advanced genomic analysis. Established in 2014, the company’s team of scientific advisors consist of scientists, physicians, and professors who are practicing real life genomics in the field every day, giving clinical meaning and the benefit of the latest scientific discoveries to DNA analysis results. By providing international genome-wide association studies (GWAS) and algorithm implementation that is based on those studies, they are able to produce the highest scientific level analysis. Having been developed internally by a team of computational biologists and organizational informatics, their algorithm relies on open tables that can easily be updated with the latest scientific data.